JPH11130679A5 - - Google Patents

Info

Publication number
JPH11130679A5
JPH11130679A5 JP1998233671A JP23367198A JPH11130679A5 JP H11130679 A5 JPH11130679 A5 JP H11130679A5 JP 1998233671 A JP1998233671 A JP 1998233671A JP 23367198 A JP23367198 A JP 23367198A JP H11130679 A5 JPH11130679 A5 JP H11130679A5
Authority
JP
Japan
Prior art keywords
nail
betamethasone
nail varnish
dipropionate
forming agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998233671A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11130679A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH11130679A publication Critical patent/JPH11130679A/ja
Publication of JPH11130679A5 publication Critical patent/JPH11130679A5/ja
Pending legal-status Critical Current

Links

JP10233671A 1997-08-21 1998-08-20 抗乾癬マニキュア液 Pending JPH11130679A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19736112:9 1997-08-21
DE19736112 1997-08-21

Publications (2)

Publication Number Publication Date
JPH11130679A JPH11130679A (ja) 1999-05-18
JPH11130679A5 true JPH11130679A5 (enExample) 2005-11-04

Family

ID=7839551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10233671A Pending JPH11130679A (ja) 1997-08-21 1998-08-20 抗乾癬マニキュア液

Country Status (35)

Country Link
US (3) US6352686B2 (enExample)
EP (1) EP0913154B1 (enExample)
JP (1) JPH11130679A (enExample)
KR (1) KR100610517B1 (enExample)
CN (1) CN1155386C (enExample)
AR (1) AR015933A1 (enExample)
AT (1) ATE227993T1 (enExample)
AU (1) AU740615B2 (enExample)
BG (1) BG63270B1 (enExample)
BR (1) BR9803756A (enExample)
CA (1) CA2245637C (enExample)
CO (1) CO4960649A1 (enExample)
CZ (1) CZ292344B6 (enExample)
DE (1) DE59806343D1 (enExample)
DK (1) DK0913154T3 (enExample)
ES (1) ES2186952T3 (enExample)
HR (1) HRP980458B1 (enExample)
HU (1) HUP9801898A3 (enExample)
ID (1) ID20731A (enExample)
IL (1) IL125854A (enExample)
MY (1) MY128558A (enExample)
NO (1) NO319391B1 (enExample)
NZ (1) NZ331443A (enExample)
PL (1) PL192342B1 (enExample)
PT (1) PT913154E (enExample)
RO (1) RO118174B1 (enExample)
RU (1) RU2210354C2 (enExample)
SG (1) SG68072A1 (enExample)
SI (1) SI0913154T1 (enExample)
SK (1) SK284218B6 (enExample)
TR (1) TR199801609A2 (enExample)
TW (1) TW590776B (enExample)
UA (1) UA51693C2 (enExample)
YU (1) YU49492B (enExample)
ZA (1) ZA987531B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
WO2002055023A2 (en) * 2001-01-09 2002-07-18 Israel Dvoretzky Therapeutic film forming composition and treatment system
FR2830449B1 (fr) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
FR2835180B1 (fr) * 2002-01-30 2004-04-09 Fiabila Vernis a ongles multiphase
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
AU2003294027B2 (en) * 2002-12-17 2009-09-10 Galderma S.A. Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
EP1854466A1 (en) * 2002-12-17 2007-11-14 Galderma Research & Development, S.N.C. Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
US7238533B1 (en) * 2003-07-22 2007-07-03 Ronald Legge Personal illicit drug detection method
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
JP4608618B2 (ja) * 2004-07-02 2011-01-12 有限会社 エヌ・ピィ・アール ネイルアート用溶液
US20060062982A1 (en) * 2004-09-17 2006-03-23 Massachusetts Institute Of Technology Carbon-polymer electrochemical systems and methods of fabricating them using layer-by-layer technology
CA2498623A1 (en) * 2005-02-18 2006-08-18 Qlt Inc. Treatment of onychomycosis
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
US8277780B2 (en) * 2005-05-27 2012-10-02 Taro Pharmaceutical North America, Inc. Stable liquid desoximethasone compositions with reduced oxidized impurity
KR100803926B1 (ko) 2006-07-27 2008-02-15 주식회사 코리아나화장품 샌드프리 화장료 조성물
US20090317341A1 (en) * 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
FR2937250B1 (fr) * 2008-10-21 2013-05-10 Fabre Pierre Dermo Cosmetique Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
PT3403654T (pt) 2009-10-01 2019-09-05 Adare Dev I L P Composições de corticosteroide administradas oralmente
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
PL233616B1 (pl) 2017-08-10 2019-11-29 Podopharm Spolka Z Ograniczona Odpowiedzialnoscia Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu
US20250332120A1 (en) * 2022-07-28 2025-10-30 Kao Corporation Composition for external preparation

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928261A (en) * 1973-05-17 1975-12-23 Minnesota Mining & Mfg Water removable film-forming compositions for topical application to skin
US3861932A (en) * 1973-12-13 1975-01-21 Revlon Stabilization of nitrocellulose
US3966924A (en) * 1974-11-13 1976-06-29 Allergan Pharmaceuticals Composition and method for treating psoriasis
US4179304A (en) * 1978-04-03 1979-12-18 Polychrome Corporation Finger nail lacquer
US4210633A (en) * 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
US4250164A (en) * 1979-04-09 1981-02-10 Bernstein Joel E Method of treating psoriasis of the nails and composition
AU599064B2 (en) * 1985-11-04 1990-07-12 Dermatological Products Of Texas Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
DE3612305A1 (de) * 1986-04-11 1987-10-22 Roehm Pharma Gmbh Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US5093108A (en) * 1989-02-16 1992-03-03 Amalia, Inc. Quick-drying nail enamel compositions and method for coating a surface
CA2008775C (en) * 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE19518262A1 (de) * 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
KR100200447B1 (ko) * 1993-07-28 1999-06-15 디. 제이. 우드, 스피겔 알렌 제이 건선의 치료를 위한 조성물
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
DE19529085A1 (de) * 1995-08-08 1997-02-13 Christiane Dr Med Wurdel Nagellack zur Bekämpfung der Schuppenflechte im Nagelbereich
JP2000512265A (ja) * 1996-03-16 2000-09-19 ヘキスト・アクチエンゲゼルシヤフト 爪の乾癬の治療のための局所投与用製剤
GB9609653D0 (en) 1996-05-09 1996-07-10 Applied Research Ars Holding N Method of assay
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia

Similar Documents

Publication Publication Date Title
JPH11130679A5 (enExample)
RU98116129A (ru) Лак для ногтей с антипсориазной активностью
CO4960649A1 (es) Esmalte para unas que contiene al menos un glucocorticoide y procedimiento de fabricacion
JP2018197259A5 (enExample)
EP2214643B1 (en) Transdermal delivery system for hormones and steroids
JP2019047820A5 (enExample)
JP2011502172A5 (enExample)
EP1465636A2 (en) Compositions and methods for enhancing corticosteriod delivery
HRP20161279T1 (hr) Kombinirani preparati s antagonistom citokina i ortikosteroidom
JP2020022787A5 (enExample)
JP2003502357A5 (enExample)
JP2013075924A (ja) 少なくとも１つのビタミンｄまたは１つのビタミンｄアナログおよび少なくとも１つのコルチコステロイドを含有する局所用組成物
CA2550811A1 (en) Temperature-stable formulations, and methods of development thereof
US4945089A (en) Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids
JP2006518382A5 (enExample)
RU2005129276A (ru) Применение стероидов для лечения субъектов, страдающих заболеванием глаз
EP2547325B1 (en) Spray-pumpable composition suitable for topical skin application
JP2020506307A (ja) 高含量の生体接着物質を有する電界紡糸繊維を調製する方法
JP2016520656A5 (enExample)
JP2004519451A5 (enExample)
RU2003119439A (ru) Фармацевтическая композиция для лечения фимоза с помощью местного кортикостериода
JP2011503109A5 (enExample)
CA2248977A1 (en) Topical formulations for the treatment of nail psoriasis
US5358943A (en) Use of tetrahydrocortisol to prevent elevations in intraocular pressure caused by corticosteroids
TW200920380A (en) Therapeutic regimens for the treatment of immunoinflammatory disorders